Your version of Internet Explorer is outdated and needs to be updated!
Please upgrade to Internet Explorer 8 or Internet Explorer 9 to experience all the features of this site.

Rhonda Cooper-DeHoff , Pharm.D., M.S., FAHA, FACC

Rhonda Cooper-DeHoff

Associate Professor

Department of Pharmacotherapy and Translational Research

OFFICE: HSC PG-25

EMAIL: dehoff@cop.ufl.edu

PHONE: 352-273-6184

 

Education

  • Pharm.D., University of California at San Francisco, School of Pharmacy
  • M.S. in Medical Sciences, emphasis in Clinical Investigation, University of Florida

BIOGRAPHICAL SKETCH

Cooper-DeHoff is a Associate Professor in the Department of Pharmacotherapy and Translational Research, and the Department of Pharmaceutics in the College of Pharmacy, and in the Division of Cardiovascular Medicine, College of Medicine at the University of Florida.

  • 2009 – Research featured by the American Society of Hypertension
  • 2008 – Received the Clinical Science Award from the Consortium for Southeastern Hypertension Control
  • 2007 – Named Fellow of the American Heart Association

Affiliations

American Society of Hypertension
American Heart Association
American College of Cardiology
Florida Society of Hospital Pharmacists
North Central Florida Society of Hospital Pharmacists

RESEARCH INTERESTS

Cooper-DeHoff’s research interest include hypertension, metabolic syndrome and diabetes, and she is the principal investigator for the NIH-funded Career Development Award (K23) entitled “Metabolic Effects of Antihypertensive Drugs.” She was also an investigator of the International Verapamil Trandolapril Study (INVEST) which evaluated hypertension treatments in elderly coronary artery disease patients, and is a co-investigator on two NIH grants evaluating pharmacogenetic associations in hypertension. She is a member of the American Heart Association, American Society of Hypertension, American College of Cardiology and Florida Society of Hospital Pharmacists.  Cooper-DeHoff serves as a scientific reviewer for several Journals, including Circulation, Annals of Pharmacotherapy, Lancet and many others.

Publications

Cooper-DeHoff RM, Egelund EF, Pepine CJ, Blood pressure lowering in patients with diabetes-one level might not fit all, Nat Rev Cardiol, 2010 Nov 16.

Navare HA, Frye RF, Cooper-DeHoff RM, et al, Atenolol exposure and risk for development of adverse metabolic effects: a pilot study, Pharmacotherapy, 2010 Sep;30(9):872-878.

Denardo SJ, Messerli FH, Gaxlola E, Aranda JM Jr, Cooper-DeHoff RM, et al, Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [IVEST]), Am J Cardiol, 2010 Aug 15;106(4):498-503.

Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-DeHoff RM, et al, Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy, Am J Med, 2010 Aug;123(8):719-726.

Cooper-DeHoff RM, Gong Y, Handberg EM, et al, Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease, JAMA, 2010 Jul 7;304(1):61-68.

Full Publication List via PubMed RSS feed

 
 
Top of Page